PRESS RELEASE published on 02/07/2023 at 12:30, 1 year 9 months ago Empower Clinics Signs Letter of Intent for Partnership to Launch US Clinical Trial Management Services for Biotech and Pharmaceutical Industries
PRESS RELEASE published on 02/02/2023 at 11:00, 1 year 9 months ago Empower Clinics Announces FOBI Partnership to Elevate Investor Relations with Digital, Mobile and Personalized Engagement
PRESS RELEASE published on 01/25/2023 at 02:45, 1 year 9 months ago Empower Clinics Subsidiary Receives Approvals for Government Reimbursement From Four Government Administrations
PRESS RELEASE published on 01/23/2023 at 23:00, 1 year 9 months ago Empower Clinics Announces $2 Million CAD Offering of Common Shares and Common Share Purchase Warrants
PRESS RELEASE published on 01/11/2023 at 12:00, 1 year 10 months ago Empower Clinics to Consolidate Operations at The Medi-Collective
PRESS RELEASE published on 01/10/2023 at 12:30, 1 year 10 months ago Empower Clinics Subsidiary Wins Laboratory Services Agreement with European Medical Products Manufacturer
PRESS RELEASE published on 01/03/2023 at 09:30, 1 year 10 months ago Empower Clinics Subsidiary Signs Laboratory Services Agreement with US Healthcare Provider for Underserved Americans
Published on 11/21/2024 at 13:30, 19 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 19 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 49 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 49 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 49 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 14 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 34 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 51 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 29 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 4 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
